Kết quả sớm và trung hạn sau nong bóng phủ thuốc (paclitaxel) trong điều trị tổn thương mạch nhỏ và tái hẹp trong Stent tại Viện Tim mạch - Bệnh viện Bạch Mai
Tóm tắt
Kết quả sớm và trung hạn sau nong bóng phủ thuốc (paclitaxel) trong điều trị tổn thương mạch nhỏ và tái hẹp trong Stent tại Viện Tim mạch - Bệnh viện Bạch MaiTài liệu tham khảo
1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-95.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restensin Study Inestigators. N Engl J Med 1994; 331: 496-501.
3. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al.
Comparison of a polymer-based pacli-taxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005; 294: 1215-23.
4. Morice MC, Serruys PW, Sousa JE, Fajadet J, BanHayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
5. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Eng J Med 2007; 357: 1393-402.
6. Kelbæk H, Kløvgaard L, Helqvist S, Lassen JF, Krusell LR, Engstrøm T, et al. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. J Am Coll Cardiol 2008; 51: 2011-6.
7. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, Lopez-Minguez JR, et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003; 42: 796-805.
8. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al.
Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005; 293: 165-71.
9. Iofina E, Haager PK, Radke PW, Langenberg R, Blindt R, Ortlepp J, et al.
Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Catheter Cardiovasc Interv 2005; 64: 28-34.
10. Alfonso F, Pérez-Vizcayno MJ, Hernández R, Bethencourt A, Martí V, López- Mínguez JR, et al. Long- Term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis: results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study. J Am Coll Cardiol 2008; 52: 1621-7.
11. Mishkel JG, Moore AL, Markwell S, Shelton MC, Shelton ME. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007; 49: 181-4.
12. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009; 103: 491-5.
13. Garg S, Smith K, Torguson R, Okabe T, Slottow TL, Steinberg DH, et al.
Treatment of drug-eluting stent restenosis with the same versus different drug- eluting stent. Catheter Cardiovasc Interv 2007; 70: 9-14.
14. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-70.
15. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcaton utrecht) registry. Catheter Cardiovasc Interv 2008; 71: 629-35.
16. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, et al. Treatment of coronary in- stent restenosis with a paclitaxel-coated balloon catheter. N Eng J Med 2006; 355: 2113-24.
17. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner G, Antoni D., Kleber F, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B., Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In- Stent Restenosis. Circulation. 2009; 119: 2986-2994.
18. Colantonio R, Romagnoli E, Sangiorgi E., Coronary Bifurcation Disease and Bifucation stenting: A practical approach. EMJ Int Cardiol. 2014;1:62-72
19. Eltchaninoff H, Koning R, Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998; 32: 980-4.
20. vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, Buettner HJ, Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002; 105: 583-8.
21. Waksman R, Cheneau E, Ajani AE, White RL, Pinnow E, Torguson R, Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In- Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003; 107: 1744-9.
